Cereno Scientific AB (publ) (STO:CRNO.B)
Sweden · Delayed Price · Currency is SEK 4.362
+0.124 (2.93%)
At close: Sep 4, 2026
Cereno Scientific AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 38.98 | 74.64 | 127.58 | 87.17 | 67.05 | 89.63 |
Cash & Short-Term Investments | 38.98 | 74.64 | 127.58 | 87.17 | 67.05 | 89.63 |
Cash Growth | -48.01% | -41.49% | 46.36% | 30.01% | -25.20% | 35.80% |
Other Receivables | 2.93 | 1.99 | 2.88 | 1.12 | 1.25 | 1.36 |
Receivables | 2.93 | 1.99 | 2.88 | 1.12 | 1.25 | 1.36 |
Prepaid Expenses | 2.32 | 1.72 | 2.54 | 0.41 | 0.33 | 0.24 |
Total Current Assets | 44.24 | 78.35 | 133 | 88.7 | 68.63 | 91.24 |
Property, Plant & Equipment | 1.6 | 1.04 | 1.27 | 0.01 | 0.03 | 0.04 |
Other Intangible Assets | 13.78 | 13.78 | 13.78 | 13.78 | 11.28 | 9.28 |
Long-Term Deferred Charges | 399.9 | 309.5 | 265.72 | 182.48 | 135.71 | 80.16 |
Other Long-Term Assets | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 |
Total Assets | 459.52 | 402.67 | 413.77 | 284.99 | 215.65 | 180.74 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 69.39 | 10.09 | 13.95 | 6.93 | 9.41 | 2.88 |
Accrued Expenses | 14.02 | 10.07 | 5.5 | 15 | 3.71 | 2.35 |
Short-Term Debt | - | - | - | - | - | 4.8 |
Current Income Taxes Payable | - | - | - | - | 0.21 | 0.03 |
Other Current Liabilities | 2.71 | 4.91 | 12 | 1.23 | 0.41 | 0.2 |
Total Current Liabilities | 86.12 | 25.08 | 31.45 | 23.16 | 13.74 | 10.27 |
Long-Term Debt | 175 | 125 | 190.4 | 45.4 | 0.4 | 0.4 |
Total Liabilities | 261.12 | 150.08 | 221.85 | 68.56 | 14.14 | 10.67 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 31.21 | 31.05 | 28.17 | 23.38 | 13.75 | 10.53 |
Additional Paid-In Capital | 407.47 | 316.2 | 271.84 | 299.08 | 245.73 | 189.76 |
Retained Earnings | -240.28 | -94.66 | -108.09 | -106.04 | -57.97 | -30.22 |
Comprehensive Income & Other | - | 0 | - | - | - | - |
Shareholders' Equity | 198.4 | 252.6 | 191.93 | 216.42 | 201.51 | 170.06 |
Total Liabilities & Equity | 459.52 | 402.67 | 413.77 | 284.99 | 215.65 | 180.74 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 175 | 125 | 190.4 | 45.4 | 0.4 | 5.2 |
Net Cash (Debt) | -136.02 | -50.36 | -62.82 | 41.77 | 66.65 | 84.43 |
Net Cash Growth | - | - | - | -37.33% | -21.07% | 49.48% |
Net Cash Per Share | -0.44 | -0.15 | -0.20 | 0.18 | 0.48 | 0.80 |
Filing Date Shares Outstanding | 312.09 | 296.64 | 281.7 | 233.78 | 137.51 | 105.26 |
Total Common Shares Outstanding | 312.09 | 296.64 | 281.7 | 233.78 | 137.51 | 105.26 |
Working Capital | -41.89 | 53.27 | 101.55 | 65.54 | 54.89 | 80.96 |
Book Value Per Share | 0.64 | 0.85 | 0.68 | 0.93 | 1.47 | 1.62 |
Tangible Book Value | 184.61 | 238.81 | 178.15 | 202.64 | 190.23 | 160.78 |
Tangible Book Value Per Share | 0.59 | 0.81 | 0.63 | 0.87 | 1.38 | 1.53 |
Machinery | - | 1.56 | 1.49 | 0.07 | 0.07 | 0.07 |